Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 15 of 62 for:    Lixisenatide

Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan (LixiRam)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02941367
Recruitment Status : Completed
First Posted : October 21, 2016
Last Update Posted : September 21, 2017
Sponsor:
Information provided by (Responsible Party):
Sanofi

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 4, 2017
Actual Study Completion Date : August 4, 2017